Response to aerosolized calfactant in infants with respiratory distress syndrome; a post-hoc analysis of AERO-02 trial

被引：2
|
作者：
Kaluarachchi, Dinushan C. C. [1 ]
Zapata, Henry A. A. [1 ]
Becker, Heather L. L. [2 ]
Lasarev, Michael R. R. [3 ]
Fort, Prem [4 ,5 ]
Guthrie, Scott O. O. [6 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Div Neonatol, Madison, WI 53715 USA
[2] UnityPoint Hlth Meriter Hosp, Dept Resp Therapy, Madison, WI USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA
[4] Johns Hopkins Univ, Dept Pediat, Div Neonatol, Sch Med, Baltimore, MD USA
[5] Johns Hopkins All Childrens Hosp, Johns Hopkins All Childrens Maternal Fetal & Neona, St Petersburg, FL USA
[6] Vanderbilt Univ, Dept Pediat, Div Neonatol, Sch Med, Nashville, TN USA
来源：
JOURNAL OF PERINATOLOGY | 2023年 / 43卷 / 08期
关键词：
SURFACTANT REPLACEMENT THERAPY; PRETERM; VENTILATION;
D O I：
10.1038/s41372-023-01717-1
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
BackgroundThe aerosolized calfactant decreased the need for intubation in neonates with respiratory distress syndrome (AERO-02 trial).ObjectiveTo determine the oxygenation response to aerosolized calfactant among infants born 28 0/7-36 6/7 weeks with RDS in the AERO-02 trial.MethodsTrends in hourly fraction of oxygen (FiO(2)), mean airway pressure (MAP) and respiratory severity score (RSS) were compared between the aerosolized calfactant (AC) and usual care (UC) groups from time of randomization for 72 h.ResultsA total of 353 subjects were included in the study. FiO(2), MAP, and RSS were lower in the UC group. FiO(2) decrease was seen after the first aerosolized calfactant dose.ConclusionFiO(2), MAP, and RSS were lower in the UC group. This is likely due to early and higher rate of liquid surfactant administration in the UC group. Decrease in FiO(2) was noted in the AC group after the first aerosolization.
引用
收藏
页码：998 / 1003
页数：6
相关论文
共 50 条
  • [31] Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
    Zepeng Mu
    Wei Wang
    Jing Wang
    Wenshan Lv
    Ying Chen
    Fang Wang
    Xiaolong Yu
    Yangang Wang
    Bingfei Cheng
    Zhongchao Wang
    Clinical Rheumatology, 2019, 38 : 3511 - 3519
  • [32] Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post-hoc analysis from the ADVOR trial
    Van den Eynde, Jef
    Martens, P.
    Dauw, J.
    Nijst, P.
    Meekers, E.
    Ter Maaten, J. M.
    Damman, K.
    Filippatos, G.
    Lassus, J.
    Mebazaa, A.
    Ruschitzka, F.
    Dupont, M.
    Mullens, W.
    Verbrugge, F. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 211 - 212
  • [33] Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
    Mu, Zepeng
    Wang, Wei
    Wang, Jing
    Lv, Wenshan
    Chen, Ying
    Wang, Fang
    Yu, Xiaolong
    Wang, Yangang
    Cheng, Bingfei
    Wang, Zhongchao
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3511 - 3519
  • [34] Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial
    Schell, Marianne
    Pflueger, Irada
    Brugnara, Gianluca
    Isensee, Fabian
    Neuberger, Ulf
    Foltyn, Martha
    Kessler, Tobias
    Sahm, Felix
    Wick, Antje
    Nowosielski, Martha
    Heiland, Sabine
    Weller, Michael
    Platten, Michael
    Maier-Hein, Klaus H.
    Von Deimling, Andreas
    van den Bent, Martin J.
    Gorlia, Thierry
    Wick, Wolfgang
    Bendszus, Martin
    Kickingereder, Philipp
    NEURO-ONCOLOGY, 2020, 22 (11) : 1667 - 1676
  • [35] Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
    Calfee, Carolyn S.
    Delucchi, Kevin L.
    Sinha, Pratik
    Matthay, Michael A.
    Hackett, Jonathan
    Shankar-Hari, Manu
    McDowell, Cliona
    Laffey, John G.
    O'Kane, Cecilia M.
    McAuley, Daniel F.
    LANCET RESPIRATORY MEDICINE, 2018, 6 (09): : 691 - 698
  • [36] BLOOD EOSINOPHILS AND SERUM IgE PREDICT RESPONSE TO OMALIZUMAB IN PATIENTS WITH SEVERE ALLERGIC ASTHMA: INNOVATE TRIAL POST-HOC ANALYSIS
    Manga, Volkan
    Humbert, Marc
    Djukanovic, Ratko
    Greenberg, Steve
    Omachi, Theodore A.
    Trzaskoma, Benjamin
    Buhl, Roland
    RESPIROLOGY, 2017, 22 : 52 - 52
  • [37] Blood Eosinophils and Serum IgE Predict Response to Omalizumab in Patients with Severe Allergic Asthma: Innovate Trial Post-Hoc Analysis
    Manga, Volkan
    Humbert, Marc
    Djukanovic, Ratko
    Greenberg, Steve
    Omachi, Theodore A.
    Trzaskoma, Benjamin
    Buhl, Roland
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB16 - AB16
  • [38] Temporal Profile Of Catheter-directed Thrombolysis On Post-thrombotic Syndrome Outcomes In Iliofemoral DVT Patients: Post-hoc Analysis Of ATTRACT Trial
    Li, Wenzhu
    Weinberg, Ido
    Lee, Hang
    Rosovsky, Rachel
    Reed, Guy L.
    Libby, Peter
    Tawakol, Ahmed A.
    Henke, Peter
    Jaffer, Farouc A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [39] Onasemnogene abeparvovec preserves bulbar function in infants with presymptomatic spinal muscular atrophy: a post-hoc analysis of the SPR1NT trial
    Shell, Richard D.
    Mcgrattan, Katlyn E.
    Hurst-Davis, Rebecca
    Young, Sally Dunaway
    Baranello, Giovanni
    Lavrov, Arseniy
    O'Brien, Eamonn
    Wallach, Shiri
    Lamarca, Nicole
    Reyna, Sandra P.
    Darras, Basil T.
    NEUROMUSCULAR DISORDERS, 2023, 33 (08) : 670 - 676
  • [40] Incidence of postoperative opioid-induced respiratory depression episodes in patients on room air or supplemental oxygen: a post-hoc analysis of the PRODIGY trial
    Doufas, Anthony G.
    Laporta, Mariana L.
    Driver, C. Noelle
    Di Piazza, Fabio
    Scardapane, Marco
    Bergese, Sergio D.
    Urman, Richard D.
    Khanna, Ashish K.
    Weingarten, Toby N.
    BMC ANESTHESIOLOGY, 2023, 23 (01)
12345